Overview

Allergic Rhinitis Combination Pharmacotherapy Efficacy Study

Status:
Not yet recruiting
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
Combination pharmacotherapy is often used in people who have failed mono-therapies in managing their bothersome allergic rhinitis symptoms . However, there is a paucity of research indicating the most effective combination therapies in managing allergic rhinitis. This study aims to evaluate the efficacy of oral antihistamine (rupatadine) combined with nasal steroid (fluticasone propionate) compared to a well-studied combination therapy of nasal steroid with nasal antihistamine spray (MP-AzeFlu).
Phase:
Phase 4
Details
Lead Sponsor:
St. Paul's Sinus Centre
Treatments:
Azelastine
Fluticasone
Xhance